Vivici
the Delft-based precision-fermentation company backed by Fonterra and DSM-Firmenich launched Vivitein LF in the United States in 2026 with self-affirmed GRAS status (February 2026) and, in June 2026,…
- Country
- Netherlands
FDA GRAS (self-affirmed Feb 2026)
EU EIC €12.5M grant (Jun 2026)
Coverage
| CN | EU | US | |
|---|---|---|---|
| food-alt-protein | ✓ | ✓ | ✓ |
Regulatorsfdaefsa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Precision-fermented infant formula | food-alt-protein | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.